Danaher Corporation (DHR)Danica Pension, Livsforsikringsaktieselskab reduced its stake -44K shares

198K

Shares reported · -44K vs prior quarter

0.60%

Disclosed portfolio weight

$37.6M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
2. Jun 26, 2026FDARecall: REF # D23354, MicroScan LabPro V5.03 Panel Update 11 DVD Kit (US) on the following instruments: - B1018-280 MicroScan autoSCAN-4 Instrument - B1018-283 MicroSc…
3. Jun 26, 2026FDARecall: REF # D23352, MicroScan LabPro V5.03 Panel Update 11 (US), Electronic installed on the following instruments: - B1018-280 MicroScan autoSCAN-4 Instrument - B10…
4. Jul 15, 2026FDARecall: Beckman Coulter DxC 500 AU Clinical Analyzer Modules using software version 1.5 or lower: 1) AU w/out ISE, Part Number C63519; 2) AU w/ISE, Part Number C63520;…
5. Jul 15, 2026FDARecall: Beckman Coulter DxC 500i Clinical Analyzer Modules using software version 1.5 or lower: 1) DxC 500 AU Module w/ISE, DxC 500i, Part Number C63522; 2) DxC 500 AU…
6. Jul 21, 2026Company filing · Form 8-K · ResultsReported its results
7. Jul 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On August 3, 2026, Danaher Corporation (the “Company” or “Danaher”) announced that, effective as of October 1, 2026 (the “Effective Date”), the Board of Directors of the Company (the “Board”) has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the “CEO”).”
8. Aug 7, 2026FDAFDA device clearance: Xpert Hemorrhagic Fever
9. Aug 7, 2026FDAFDA device clearance: Aperio iQC DX Software
10. Aug 7, 2026FDAFDA device clearance: Aperio GT 450 DX; Aperio GT 180 DX

What came next

1. Aug 21, 2026Insider · 1 personInsiders: 3 sales (~$12.7M)
2. Aug 31, 2026CongressDisclosed sale of DHR — reported range $15,001 - $50,000
3. Sep 2, 2026CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
4. Sep 21, 2026FDAFDA device clearance: Access NT-proBNP
5. Sep 25, 2026FDAFDA device clearance: Xpert Respiratory Panel

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 86 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

• SEC Form 13F

Other disclosures at Danaher Corporation

• House Clerk periodic transaction reportSep 25, 2026
• House Clerk periodic transaction reportSep 25, 2026
• SEC Form 4Aug 24, 2026
• SEC Form 4Aug 24, 2026
• SEC Form 4Aug 24, 2026
• SEC Form 13F-HRAug 18, 2026

Everything OQRO holds on this company is on its DHR page.